| Ketorolac | hsa00030 | Pentose phosphate pathway | 3.74E-02 | 2 | P60891, P52209 | PRPS1, PGD | More | |
| Ketorolac | hsa00052 | Galactose metabolism | 4.27E-02 | 2 | P06280, O43451 | GLA, MGAM | More | |
| Ketorolac | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | |
| Ketorolac | hsa00190 | Oxidative phosphorylation | 1.39E-03 | 4 | Q16718, Q13488, P36542, O14521 | NDUFA5, TCIRG1, ATP5C1, SDHD | More | |
| Ketorolac | hsa00220 | Arginine biosynthesis | 1.43E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | |
| Ketorolac | hsa00230 | Purine metabolism | 1.81E-02 | 2 | P20839, Q02153 | IMPDH1, GUCY1B3 | More | |
| Ketorolac | hsa00260 | Glycine, serine and threonine metabolism | 1.99E-02 | 1 | P22557 | ALAS2 | More | |
| Ketorolac | hsa00330 | Arginine and proline metabolism | 4.86E-02 | 1 | P17707 | AMD1 | More | |
| Ketorolac | hsa00480 | Glutathione metabolism | 3.29E-04 | 4 | Q9UJ14, Q16772, P09211, P30041 | GGTL3, GSTA3, GSTP1, PRDX6 | More | |
| Ketorolac | hsa00500 | Starch and sucrose metabolism | 6.17E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | |
| Ketorolac | hsa00565 | Ether lipid metabolism | 3.00E-03 | 1 | Q8N661 | TMEM86B | More | |
| Ketorolac | hsa00630 | Glyoxylate and dicarboxylate metabolism | 3.73E-04 | 3 | P40925, P40926, P15104 | MDH1, MDH2, GLUL | More | |
| Ketorolac | hsa00730 | Thiamine metabolism | 2.27E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | |
| Ketorolac | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.12E-02 | 1 | P14868 | DARS | More | |
| Ketorolac | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | |
| Ketorolac | hsa00982 | Drug metabolism - cytochrome P450 | 1.06E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | |
| Ketorolac | hsa00983 | Drug metabolism - other enzymes | 1.72E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | |
| Ketorolac | hsa01100 | Metabolic pathways | 8.43E-03 | 11 | P35790, Q16772, P09211, Q9UJ14, P30041, P40926, Q7KZN9, P15121, Q9UHK6, Q86VZ5, Q9BQB6 | CHKA, GSTA3, GSTP1, GGTL3, PRDX6, MDH2, COX15, AKR1B1, AMACR, SGMS1, VKORC1 | More | |
| Ketorolac | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.82E-02 | 1 | P08069 | IGF1R | More | |
| Ketorolac | hsa01522 | Endocrine resistance | 2.16E-02 | 1 | P08069 | IGF1R | More | |
| Ketorolac | hsa01524 | Platinum drug resistance | 4.44E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | |
| Ketorolac | hsa02010 | ABC transporters | 2.17E-03 | 1 | Q8IZY2 | ABCA7 | More | |
| Ketorolac | hsa03013 | RNA transport | 2.85E-07 | 21 | O14980, P52298, Q09161, O14893, Q15287, Q9UBU9, Q7Z3B4, P35658, P63279, P47813, Q14152, P55884, O15371, O75822, P78345, P20042, Q14240, Q9BZI7, Q9Y6A5, Q06787, P51114 | XPO1, NCBP2, NCBP1, GEMIN2, RNPS1, NXF1, NUP54, NUP214, UBE2I, EIF1AX, EIF3A, EIF3B, EIF3D, EIF3J, RPP38, EIF2S2, EIF4A2, UPF3B, TACC3, FMR1, FXR1 | More | | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
|---|
| Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | O14980 | XPO1 | Exportin-1 | 0.799 | | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.888 | | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | 0.771 | | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | 0.742 | | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.72 | | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.853 | | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q15287 | RNPS1 | RNA-binding protein with serine-rich domain 1 | 0.756 | | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q9UBU9 | NXF1 | Nuclear RNA export factor 1 | 0.723 | | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.883 | | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.774 | | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.708 | | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.725 | | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.751 | | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.736 | | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | P47813 | EIF1AX | Eukaryotic translation initiation factor 1A, X-chromosomal | 0.844 | | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.869 | | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.734 | | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P55884 | EIF3B | Eukaryotic translation initiation factor 3 subunit B | -0.731 | | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | O15371 | EIF3D | Eukaryotic translation initiation factor 3 subunit D | 0.77 | | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.77 | | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.837 | | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P78345 | RPP38 | Ribonuclease P protein subunit p38 | 0.852 | | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P20042 | EIF2S2 | Eukaryotic translation initiation factor 2 subunit 2 | 0.733 | | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q14240 | EIF4A2 | Eukaryotic initiation factor 4A-II | 0.849 | | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q9BZI7 | UPF3B | Regulator of nonsense transcripts 3B | 0.764 | | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | -0.812 | | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q06787 | FMR1 | Synaptic functional regulator FMR1 | 0.863 | | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | P51114 | FXR1 | Fragile X mental retardation syndrome-related protein 1 | 0.798 |
|
| Ketorolac | hsa03022 | Basal transcription factors | 3.50E-02 | 3 | P20226, O00268, Q15544 | TBP, TAF4, TAF11 | More | |
| Ketorolac | hsa03030 | DNA replication | 5.00E-02 | 1 | P27694 | RPA1 | More | |
| Ketorolac | hsa03040 | Spliceosome | 3.38E-05 | 12 | Q14562, O43143, O60508, P17844, Q15427, P51991, P38159, P61978, Q07955, Q01130, Q13243, P11142 | DHX8, DHX15, CDC40, DDX5, SF3B4, HNRPA3, RBMX, HNRPK, SFRS1, SFRS2, SFRS5, HSPA8 | More | |
| Ketorolac | hsa03060 | Protein export | 1.43E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | |
| Ketorolac | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | |
| Ketorolac | hsa04010 | MAPK signaling pathway | 4.15E-02 | 1 | P08069 | IGF1R | More | |
| Ketorolac | hsa04012 | ErbB signaling pathway | 3.74E-02 | 3 | P21860, Q13557, O14944 | ERBB3, CAMK2D, EREG | More | |
| Ketorolac | hsa04014 | Ras signaling pathway | 3.65E-02 | 1 | P08069 | IGF1R | More | |
| Ketorolac | hsa04015 | Rap1 signaling pathway | 2.99E-02 | 1 | P08069 | IGF1R | More | |
| Ketorolac | hsa04020 | Calcium signaling pathway | 9.75E-05 | 7 | Q96DU7, P45880, Q13557, P21860, P0DP24, P51828, P23634 | ITPKC, VDAC2, CAMK2D, ERBB3, CALM2, ADCY7, ATP2B4 | More | |
| Ketorolac | hsa04022 | cGMP-PKG signaling pathway | 4.72E-02 | 4 | Q99941, P23634, P51828, P45880 | CREBL1, ATP2B4, ADCY7, VDAC2 | More | |
| Ketorolac | hsa04024 | cAMP signaling pathway | 4.30E-03 | 7 | P51828, P42338, P0DP24, P0DP23, P23634, Q13370, Q13009 | ADCY7, PIK3CB, CALM2, CALM1, ATP2B4, PDE3B, TIAM1 | More | |
| Ketorolac | hsa04064 | NF-kappa B signaling pathway | 4.09E-03 | 8 | P10415, O00463, Q04759, Q9UDY8, Q16548, Q13315, P24522, P09341 | BCL2, TRAF5, PRKCQ, MALT1, BCL2A1, ATM, GADD45A, CXCL1 | More | |
| Ketorolac | hsa04066 | HIF-1 signaling pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | |
| Ketorolac | hsa04068 | FoxO signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | |
| Ketorolac | hsa04070 | Phosphatidylinositol signaling system | 3.21E-03 | 5 | P0DP23, P42338, Q86XP1, P27987, Q96DU7 | CALM1, PIK3CB, DGKH, ITPKB, ITPKC | More | |
| Ketorolac | hsa04071 | Sphingolipid signaling pathway | 8.69E-04 | 7 | P21453, Q9H228, Q13510, Q13362, Q9BX95, P10415, Q9UQC2 | S1PR1, EDG8, ASAH1, PPP2R5C, SGPP1, BCL2, GAB2 | More | |
| Ketorolac | hsa04080 | Neuroactive ligand-receptor interaction | 1.00E-02 | 7 | P08311, Q15722, P21453, Q9H228, O00398, P21730, P07550 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, ADRB2 | More | |
| Ketorolac | hsa04114 | Oocyte meiosis | 8.58E-05 | 9 | P51812, Q02750, P0DP24, P16298, Q17RY0, P51828, P27348, Q13362, P08069 | RPS6KA3, MAP2K1, CALM2, PPP3CB, CPEB4, ADCY7, YWHAQ, PPP2R5C, IGF1R | More | |
| Ketorolac | hsa04120 | Ubiquitin mediated proteolysis | 3.55E-03 | 4 | Q13042, Q15751, O95071, P0CG47 | CDC16, HERC1, UBR5, UBB | More | |
| Ketorolac | hsa04137 | Mitophagy - animal | 9.52E-03 | 2 | Q07817, P0CG47 | BCL2L1, UBB | More | |
| Ketorolac | hsa04140 | Autophagy - animal | 2.95E-02 | 5 | P08069, P22694, Q14643, P10415, Q04759 | IGF1R, PRKACB, ITPR1, BCL2, PRKCQ | More | |
| Ketorolac | hsa04141 | Protein processing in endoplasmic reticulum | 2.94E-04 | 8 | P18848, Q15437, Q99941, O75460, P11142, Q9H3Z4, P07900, Q9NR31 | ATF4, SEC23B, CREBL1, ERN1, HSPA8, DNAJC5, HSP90AA1, SAR1A | More | |
| Ketorolac | hsa04142 | Lysosome | 2.01E-03 | 6 | P22304, P38571, Q13510, Q9UJJ9, P07602, P49279 | IDS, LIPA, ASAH1, GNPTG, PSAP, SLC11A1 | More | |
| Ketorolac | hsa04144 | Endocytosis | 4.94E-03 | 6 | P0DMV8, Q9H444, P62491, Q8WU79, Q14161, Q9UMY4 | HSPA1A, CHMP4B, RAB11A, SMAP1L, GIT2, SNX12 | More | |
| Ketorolac | hsa04145 | Phagosome | 2.69E-04 | 9 | Q15080, P14598, Q13509, P68371, Q13488, P05164, O60603, P35443, P13765 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, MPO, TLR2, THBS4, HLA-DOB | More | |
| Ketorolac | hsa04146 | Peroxisome | 4.83E-02 | 4 | O96011, P56589, Q9UKG9, O75521 | PEX11B, PEX3, CROT, ECI2 | More | |
| Ketorolac | hsa04150 | mTOR signaling pathway | 7.74E-03 | 4 | P08069, Q02750, Q9NQL2, P51812 | IGF1R, MAP2K1, RRAGD, RPS6KA3 | More | |
| Ketorolac | hsa04151 | PI3K-Akt signaling pathway | 3.91E-03 | 7 | P62753, P27348, P07900, P22105, Q99941, P18848, O00141 | RPS6, YWHAQ, HSP90AA1, TNXB, CREBL1, ATF4, SGK | More | |
| Ketorolac | hsa04152 | AMPK signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | |
| Ketorolac | hsa04210 | Apoptosis | 3.44E-02 | 7 | Q13315, P10415, O76075, P24522, Q16548, P43234, Q14643 | ATM, BCL2, DFFB, GADD45A, BCL2A1, CTSO, ITPR1 | More | |
| Ketorolac | hsa04211 | Longevity regulating pathway | 5.33E-03 | 4 | P08069, P51828, Q99941, P18848 | IGF1R, ADCY7, CREBL1, ATF4 | More | |
| Ketorolac | hsa04213 | Longevity regulating pathway - multiple species | 9.98E-03 | 3 | P08069, Q08828, P0DMV8 | IGF1R, ADCY1, HSPA1A | More | |
| Ketorolac | hsa04261 | Adrenergic signaling in cardiomyocytes | 5.92E-05 | 7 | P51828, Q99941, P18848, Q13362, P0DP24, Q13557, P23634 | ADCY7, CREBL1, ATF4, PPP2R5C, CALM2, CAMK2D, ATP2B4 | More | |
| Ketorolac | hsa04270 | Vascular smooth muscle contraction | 1.53E-02 | 4 | P0DP23, Q08828, P35579, P35318 | CALM1, ADCY1, MYH9, ADM | More | |
| Ketorolac | hsa04330 | Notch signaling pathway | 4.34E-02 | 2 | Q92542, P46531 | NCSTN, NOTCH1 | More | |
| Ketorolac | hsa04340 | Hedgehog signaling pathway | 3.09E-02 | 3 | P22694, Q13635, P10415 | PRKACB, PTCH1, BCL2 | More | |
| Ketorolac | hsa04360 | Axon guidance | 1.71E-02 | 4 | P20827, O95631, P42338, P23528 | EFNA1, NTN1, PIK3CB, CFL1 | More | |
| Ketorolac | hsa04370 | VEGF signaling pathway | 2.68E-03 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | |
| Ketorolac | hsa04380 | Osteoclast differentiation | 1.02E-02 | 6 | Q9UQC2, Q16539, P14778, O75015, P01375, Q8N149 | GAB2, MAPK14, IL1R1, FCGR3B, TNF, LILRA2 | More | |
| Ketorolac | hsa04510 | Focal adhesion | 3.48E-02 | 1 | P08069 | IGF1R | More | |
| Ketorolac | hsa04514 | Cell adhesion molecules | 1.22E-02 | 2 | P23229, P30511 | ITGA6, HLA-F | More | |
| Ketorolac | hsa04520 | Adherens junction | 8.29E-03 | 1 | P08069 | IGF1R | More | |
| Ketorolac | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.99E-02 | 1 | P08069 | IGF1R | More | |
| Ketorolac | hsa04610 | Complement and coagulation cascades | 4.27E-06 | 1 | P0C0L4 | C4A | More | |
| Ketorolac | hsa04612 | Antigen processing and presentation | 1.28E-03 | 6 | P13765, P26715, P26717, Q07444, Q13241, P01732 | HLA-DOB, KLRC1, KLRC2, KLRC3, KLRD1, CD8A | More | |
| Ketorolac | hsa04613 | Neutrophil extracellular trap formation | 4.93E-02 | 8 | O60603, P05164, P08246, Q9UM07, Q15080, P20160, P08311, P21730 | TLR2, MPO, ELA2, PADI4, NCF4, AZU1, CTSG, C5AR1 | More | |
| Ketorolac | hsa04625 | C-type lectin receptor signaling pathway | 3.87E-02 | 4 | Q9ULY5, P20749, P01375, Q16539 | CLEC4E, BCL3, TNF, MAPK14 | More | |
| Ketorolac | hsa04650 | Natural killer cell mediated cytotoxicity | 1.31E-06 | 12 | P16298, P50591, P06239, O60880, P20963, Q02750, Q13241, P26718, O14931, P26717, Q07444, P26715 | PPP3CB, TNFSF10, LCK, SH2D1A, CD247, MAP2K1, KLRD1, KLRK1, NCR3, KLRC2, KLRC3, KLRC1 | More | |
| Ketorolac | hsa04657 | IL-17 signaling pathway | 1.36E-02 | 5 | O00463, Q16539, P49841, P14780, P01375 | TRAF5, MAPK14, GSK3B, MMP9, TNF | More | |
| Ketorolac | hsa04658 | Th1 and Th2 cell differentiation | 3.33E-07 | 9 | Q04759, P20963, P09693, P06239, Q14765, P23771, Q9UL17, P13765, Q13761 | PRKCQ, CD247, CD3G, LCK, STAT4, GATA3, TBX21, HLA-DOB, RUNX3 | More | |
| Ketorolac | hsa04659 | Th17 cell differentiation | 2.51E-05 | 11 | Q04759, P06239, P42224, P14784, P13765, P40189, Q9UL17, P23771, P08238, P09693, P20963 | PRKCQ, LCK, STAT1, IL2RB, HLA-DOB, IL6ST, TBX21, GATA3, HSP90AB1, CD3G, CD247 | More | |
| Ketorolac | hsa04660 | T cell receptor signaling pathway | 3.80E-05 | 9 | Q9UDY8, Q04759, P10747, O95267, Q08881, P20963, P09693, P01732, P06239 | MALT1, PRKCQ, CD28, RASGRP1, ITK, CD247, CD3G, CD8A, LCK | More | |
| Ketorolac | hsa04664 | Fc epsilon RI signaling pathway | 3.98E-02 | 3 | P01375, Q16539, Q9UQC2 | TNF, MAPK14, GAB2 | More | |
| Ketorolac | hsa04666 | Fc gamma R-mediated phagocytosis | 2.25E-03 | 6 | P42338, P23528, P06396, O14494, P14598, P17252 | PIK3CB, CFL1, GSN, PLPP1, NCF1, PRKCA | More | |
| Ketorolac | hsa04668 | TNF signaling pathway | 2.47E-03 | 8 | P01375, O00463, Q16539, Q99941, P01584, P20749, P14780, O95429 | TNF, TRAF5, MAPK14, CREBL1, IL1B, BCL3, MMP9, BAG4 | More | |
| Ketorolac | hsa04672 | Intestinal immune network for IgA production | 1.62E-02 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | |
| Ketorolac | hsa04714 | Thermogenesis | 3.31E-02 | 4 | P51828, P62753, P12074, O15239 | ADCY7, RPS6, COX6A1, NDUFA1 | More | |
| Ketorolac | hsa04720 | Long-term potentiation | 1.38E-02 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | |
| Ketorolac | hsa04725 | Cholinergic synapse | 2.17E-02 | 3 | P51828, P18848, Q13557 | ADCY7, ATF4, CAMK2D | More | |
| Ketorolac | hsa04728 | Dopaminergic synapse | 4.78E-02 | 3 | Q99941, P18848, Q13557 | CREBL1, ATF4, CAMK2D | More | |
| Ketorolac | hsa04730 | Long-term depression | 3.01E-03 | 2 | Q14344, P08069 | GNA13, IGF1R | More | |
| Ketorolac | hsa04744 | Phototransduction | 2.80E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | |
| Ketorolac | hsa04750 | Inflammatory mediator regulation of TRP channels | 3.74E-02 | 3 | P01584, P51828, Q13557 | IL1B, ADCY7, CAMK2D | More | |
| Ketorolac | hsa04810 | Regulation of actin cytoskeleton | 2.68E-02 | 2 | P23229, Q14344 | ITGA6, GNA13 | More | |
| Ketorolac | hsa04911 | Insulin secretion | 2.03E-05 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | |
| Ketorolac | hsa04912 | GnRH signaling pathway | 1.58E-03 | 6 | Q08828, P51828, P18848, Q13557, Q9Y6R4, P0DP23 | ADCY1, ADCY7, ATF4, CAMK2D, MAP3K4, CALM1 | More | |
| Ketorolac | hsa04913 | Ovarian steroidogenesis | 1.16E-02 | 1 | P08069 | IGF1R | More | |
| Ketorolac | hsa04914 | Progesterone-mediated oocyte maturation | 9.67E-04 | 7 | P08069, Q17RY0, P42338, Q13370, P08238, P51812, Q02750 | IGF1R, CPEB4, PIK3CB, PDE3B, HSP90AB1, RPS6KA3, MAP2K1 | More | |
| Ketorolac | hsa04915 | Estrogen signaling pathway | 7.94E-06 | 9 | Q99941, P18848, Q08828, P51828, P07900, P0DMV8, P11142, P0DP23, Q15788 | CREBL1, ATF4, ADCY1, ADCY7, HSP90AA1, HSPA1A, HSPA8, CALM1, NCOA1 | More | |
| Ketorolac | hsa04916 | Melanogenesis | 4.80E-02 | 4 | P0DP23, Q9UJU2, P17252, P04628 | CALM1, LEF1, PRKCA, WNT1 | More | |
| Ketorolac | hsa04918 | Thyroid hormone synthesis | 1.69E-03 | 4 | P51828, Q99941, P18848, P02768 | ADCY7, CREBL1, ATF4, ALB | More | |
| Ketorolac | hsa04922 | Glucagon signaling pathway | 4.23E-02 | 4 | P22694, P06737, Q12778, Q14643 | PRKACB, PYGL, FOXO1, ITPR1 | More | |
| Ketorolac | hsa04924 | Renin secretion | 1.16E-04 | 5 | P22694, P07550, Q14643, Q13370, P0DP23 | PRKACB, ADRB2, ITPR1, PDE3B, CALM1 | More | |
| Ketorolac | hsa04925 | Aldosterone synthesis and secretion | 9.59E-07 | 6 | Q99941, P18848, P51828, P0DP24, Q13557, P23634 | CREBL1, ATF4, ADCY7, CALM2, CAMK2D, ATP2B4 | More | |
| Ketorolac | hsa04926 | Relaxin signaling pathway | 3.34E-02 | 3 | Q99941, P18848, P51828 | CREBL1, ATF4, ADCY7 | More | |
| Ketorolac | hsa04927 | Cortisol synthesis and secretion | 4.16E-03 | 3 | Q99941, P18848, P51828 | CREBL1, ATF4, ADCY7 | More | |
| Ketorolac | hsa04928 | Parathyroid hormone synthesis, secretion and action | 3.09E-03 | 7 | Q14643, P51828, P22694, P23771, Q99941, P18848, P10415 | ITPR1, ADCY7, PRKACB, GATA3, CREBL1, ATF4, BCL2 | More | |
| Ketorolac | hsa04934 | Cushing syndrome | 1.09E-05 | 5 | Q99941, P18848, P51828, O15169, Q13557 | CREBL1, ATF4, ADCY7, AXIN1, CAMK2D | More | |
| Ketorolac | hsa04935 | Growth hormone synthesis, secretion and action | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | |
| Ketorolac | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 2.09E-02 | 2 | P23634, P62491 | ATP2B4, RAB11A | More | |
| Ketorolac | hsa04964 | Proximal tubule bicarbonate reclamation | 2.17E-03 | 1 | P00918 | CA2 | More | |
| Ketorolac | hsa04966 | Collecting duct acid secretion | 2.17E-03 | 1 | P00918 | CA2 | More | |
| Ketorolac | hsa04970 | Salivary secretion | 1.65E-04 | 6 | P07550, Q08828, P51828, P23634, P0DP24, P0DP23 | ADRB2, ADCY1, ADCY7, ATP2B4, CALM2, CALM1 | More | |
| Ketorolac | hsa04971 | Gastric acid secretion | 1.48E-02 | 3 | P51828, P15311, Q13557 | ADCY7, VIL2, CAMK2D | More | |
| Ketorolac | hsa04972 | Pancreatic secretion | 4.94E-03 | 3 | P23634, P51828, P62491 | ATP2B4, ADCY7, RAB11A | More | |
| Ketorolac | hsa05010 | Alzheimer disease | 2.07E-02 | 7 | Q92542, P05496, P12074, O75460, P01584, O15169, P45880 | NCSTN, ATP5G1, COX6A1, ERN1, IL1B, AXIN1, VDAC2 | More | |
| Ketorolac | hsa05014 | Amyotrophic lateral sclerosis | 2.72E-02 | 10 | P01375, Q16718, O14521, P36542, P09651, Q7Z3B4, P35658, P43243, Q09161, Q16629 | TNF, NDUFA5, SDHD, ATP5C1, HNRNPA1, NUP54, NUP214, MATR3, NCBP1, SFRS7 | More | |
| Ketorolac | hsa05020 | Prion disease | 1.81E-02 | 7 | P01584, P46531, P11142, P05496, P12074, P45880, Q99941 | IL1B, NOTCH1, HSPA8, ATP5G1, COX6A1, VDAC2, CREBL1 | More | |
| Ketorolac | hsa05030 | Cocaine addiction | 4.87E-02 | 2 | Q99941, P18848 | CREBL1, ATF4 | More | |
| Ketorolac | hsa05031 | Amphetamine addiction | 6.41E-03 | 3 | Q13557, Q99941, P18848 | CAMK2D, CREBL1, ATF4 | More | |
| Ketorolac | hsa05132 | Salmonella infection | 2.93E-02 | 10 | P51617, Q9UJU2, Q13489, P10415, O75369, O60603, Q9BQS8, Q13561, Q13509, P68371 | IRAK1, LEF1, BIRC3, BCL2, FLNB, TLR2, FYCO1, DCTN2, TUBB3, TUBB2C | More | |
| Ketorolac | hsa05133 | Pertussis | 3.02E-03 | 1 | P0C0L4 | C4A | More | |
| Ketorolac | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | |
| Ketorolac | hsa05144 | Malaria | 3.09E-02 | 2 | P69905, P68871 | HBA2, HBB | More | |
| Ketorolac | hsa05146 | Amoebiasis | 2.73E-02 | 4 | P09341, P05089, P12814, P08311 | CXCL1, ARG1, ACTN1, CTSG | More | |
| Ketorolac | hsa05150 | Staphylococcus aureus infection | 4.54E-04 | 8 | P0C0L4, P21462, O75015, P13646, Q14532, P59665, P59666, P12838 | C4A, FPR1, FCGR3B, KRT13, KRT32, DEFA1; DEFA1B, DEFA3, DEFA4 | More | |
| Ketorolac | hsa05152 | Tuberculosis | 5.68E-03 | 9 | Q13488, P0DP23, P48382, O60603, P10415, P13765, P01568, Q9UDY8, P51617 | TCIRG1, CALM1, RFX5, TLR2, BCL2, HLA-DOB, IFNA21, MALT1, IRAK1 | More | |
| Ketorolac | hsa05161 | Hepatitis B | 3.34E-02 | 3 | Q99941, P18848, P27348 | CREBL1, ATF4, YWHAQ | More | |
| Ketorolac | hsa05163 | Human cytomegalovirus infection | 5.22E-03 | 8 | P01375, P30511, Q14344, P49841, P14778, P25025, Q16539, O00463 | TNF, HLA-F, GNA13, GSK3B, IL1R1, CXCR2, MAPK14, TRAF5 | More | |
| Ketorolac | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.94E-02 | 4 | P62879, P16298, Q02750, P0CG47 | GNB2, PPP3CB, MAP2K1, UBB | More | |
| Ketorolac | hsa05168 | Herpes simplex virus 1 infection | 1.15E-02 | 8 | P42224, Q07955, Q01130, Q13243, P42338, Q13398, Q03923, Q9UDV6 | STAT1, SFRS1, SFRS2, SFRS5, PIK3CB, ZNF211, ZNF85, ZNF212 | More | |
| Ketorolac | hsa05170 | Human immunodeficiency virus 1 infection | 1.24E-04 | 17 | Q02750, P62873, P62879, P16298, P0DP23, Q05397, P17252, O00463, Q14643, P01568, P51617, O60603, P23528, P10415, Q93034, Q9Y6Q5, P20333 | MAP2K1, GNB1, GNB2, PPP3CB, CALM1, PTK2, PRKCA, TRAF5, ITPR1, IFNA21, IRAK1, TLR2, CFL1, BCL2, CUL5, AP1M2, TNFRSF1B | More | |
| Ketorolac | hsa05200 | Pathways in cancer | 3.92E-02 | 9 | P42338, P08238, P42224, P43246, P14923, O75293, P0DP23, P14784, P40189 | PIK3CB, HSP90AB1, STAT1, MSH2, JUP, GADD45B, CALM1, IL2RB, IL6ST | More | |
| Ketorolac | hsa05202 | Transcriptional misregulation in cancer | 2.54E-04 | 15 | Q12778, Q15532, Q13315, P14780, P14923, Q16548, Q13489, Q13077, O15550, P08069, P35226, P05164, P08246, Q9C0K0, P24522 | FOXO1, SS18, ATM, MMP9, JUP, BCL2A1, BIRC3, TRAF1, UTX, IGF1R, BMI1, MPO, ELA2, BCL11B, GADD45A | More | |
| Ketorolac | hsa05203 | Viral carcinogenesis | 1.75E-03 | 7 | Q12933, Q99941, P18848, P42229, P27348, Q15283, P61978 | TRAF2, CREBL1, ATF4, STAT5A, YWHAQ, RASA2, HNRPK | More | |
| Ketorolac | hsa05204 | Chemical carcinogenesis | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | |
| Ketorolac | hsa05205 | Proteoglycans in cancer | 4.93E-03 | 11 | Q13009, Q12955, Q14643, O75369, P14780, P17252, O60603, P08069, P04628, Q13635, P08962 | TIAM1, ANK3, ITPR1, FLNB, MMP9, PRKCA, TLR2, IGF1R, WNT1, PTCH1, CD63 | More | |
| Ketorolac | hsa05206 | MicroRNAs in cancer | 2.97E-03 | 6 | P15311, P21860, P61978, P46531, P63279, P22105 | VIL2, ERBB3, HNRPK, NOTCH1, UBE2I, TNXB | More | |
| Ketorolac | hsa05212 | Pancreatic cancer | 1.72E-02 | 3 | P42338, P42224, O75293 | PIK3CB, STAT1, GADD45B | More | |
| Ketorolac | hsa05213 | Endometrial cancer | 3.79E-02 | 2 | O15169, Q02750 | AXIN1, MAP2K1 | More | |
| Ketorolac | hsa05214 | Glioma | 1.88E-03 | 4 | P08069, P0DP23, P42338, O75293 | IGF1R, CALM1, PIK3CB, GADD45B | More | |
| Ketorolac | hsa05215 | Prostate cancer | 1.33E-02 | 1 | P08069 | IGF1R | More | |
| Ketorolac | hsa05218 | Melanoma | 6.63E-03 | 1 | P08069 | IGF1R | More | |
| Ketorolac | hsa05224 | Breast cancer | 1.49E-02 | 1 | P08069 | IGF1R | More | |
| Ketorolac | hsa05225 | Hepatocellular carcinoma | 1.33E-02 | 1 | P08069 | IGF1R | More | |
| Ketorolac | hsa05226 | Gastric cancer | 3.79E-02 | 2 | Q02750, O15169 | MAP2K1, AXIN1 | More | |
| Ketorolac | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.86E-04 | 7 | O95267, P20963, P09693, P06239, O60603, P10747, Q04759 | RASGRP1, CD247, CD3G, LCK, TLR2, CD28, PRKCQ | More | |
| Ketorolac | hsa05320 | Autoimmune thyroid disease | 8.64E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | |
| Ketorolac | hsa05321 | Inflammatory bowel disease | 1.17E-03 | 5 | O60603, P13765, Q14765, Q9UL17, P23771 | TLR2, HLA-DOB, STAT4, TBX21, GATA3 | More | |
| Ketorolac | hsa05322 | Systemic lupus erythematosus | 1.57E-02 | 4 | P08311, P62807, Q16778, P12814 | CTSG, HIST1H2BC, HIST2H2BE, ACTN1 | More | |
| Ketorolac | hsa05323 | Rheumatoid arthritis | 1.60E-02 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | |
| Ketorolac | hsa05332 | Graft-versus-host disease | 3.45E-03 | 4 | P13765, P10747, P26715, Q13241 | HLA-DOB, CD28, KLRC1, KLRD1 | More | |
| Ketorolac | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 2.17E-03 | 1 | P54284 | CACNB3 | More | |
| Ketorolac | hsa05414 | Dilated cardiomyopathy | 4.55E-02 | 2 | P54284, P26678 | CACNB3, PLN | More | |
| Ketorolac | hsa05418 | Fluid shear stress and atherosclerosis | 1.40E-04 | 11 | Q16539, P42338, Q14145, P14598, P10599, P14780, P01375, P14778, P27930, P0DP23, P08238 | MAPK14, PIK3CB, KEAP1, NCF1, TXN, MMP9, TNF, IL1R1, IL1R2, CALM1, HSP90AB1 | More | |
